Novavax
NVAX
$48.00
Share price
-7.50%
Change (1 day)
-65.75%
Change (1 year)
Categories
Revenue for Novavax (NVAX)
Revenue in 2021 (TTM): $1.14 B
According to Novavax's latest financial reports the company's current revenue (TTM) is $1.14 B. In 2020 the company made a revenue of $0.47 B an increase over the years 2019 revenue that were of $0.01 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Novavax from 2001 to 2021
| Year | Revenue | Change |
|---|---|---|
| 2021 (TTM) | $1.14 B | 141.02% |
| 2020 | $0.47 B | 2448.48% |
| 2019 | $0.01 B | -45.57% |
| 2018 | $0.03 B | 9.98% |
| 2017 | $0.03 B | 103.06% |
| 2016 | $0.01 B | -57.65% |
| 2015 | $0.03 B | 18.24% |
| 2014 | $0.03 B | 46.6% |
| 2013 | $0.02 B | -5.26% |
| 2012 | $0.02 B | 50.3% |
| 2011 | $0.01 B | 4182.22% |
| 2010 | $0.34 M | 5.54% |
| 2009 | $0.32 M | -69.45% |
| 2008 | $1.06 M | |
| 2006 | $4.68 M | -36.61% |
| 2005 | $7.38 M | -17.21% |
| 2004 | $8.92 M | -24.28% |
| 2003 | $0.01 B | -21.45% |
| 2002 | $0.01 B | -37.65% |
| 2001 | $0.02 B |